SUBSCRIBE
SUBSCRIBE

Panbela Therapeutics Inc.

IN THE PRESS
Drug Development
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2022 ASCO GI Meeting
January 24, 2022
 · 
7 min read
Drug Development
Panbela Announces Positive Preclinical Data Strongly Supporting the Activity of SBP-101 in Ovarian Cancer Cell Lines; Development Program for SBP-101’s Expansion into Ovarian Cancer Expected in 1H 2022
December 14, 2021
 · 
5 min read
BioMidwest
Panbela Announces Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Gastrointestinal Cancers Symposium
November 18, 2021
 · 
5 min read
Business
Panbela Provides Business Update and Reports Q3 2021 Financial Results
November 10, 2021
 · 
10 min read
Business
Panbela Schedules Conference Call on November 10, 2021, to Report 2021 Third Quarter Financial Results
October 25, 2021
 · 
5 min read
BioMidwest
Panbela to Present at Upcoming Investor Conferences
September 7, 2021
 · 
5 min read
Business
Panbela Provides Business Update and Reports Q2 2021 Financial Results
August 11, 2021
 · 
12 min read
BioMidwest
Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101Patent developed in collaboration with Syngene International Ltd
August 9, 2021
 · 
6 min read
Business
Panbela Schedules Conference Call on August 11, 2021, to Report 2021 Second Quarter Financial Results
July 28, 2021
 · 
4 min read
BioMidwest
Panbela to Present at Access to Giving Virtual Conference on July 15, 2021, at 10:30 a.m. ET
July 7, 2021
 · 
5 min read
Load More
JOBS